An experienced pharmacist, Taunia Markvicka holds a bachelor of science in pharmacy from Creighton University and a doctor of pharmacy from the University of Nebraska Medical Center, Omaha (UNO). She worked full time as a hospital pharmacist while attending UNO and completed a two-year fellowship with Rutgers University/Novartis Pharmaceuticals after earning her doctorate. Taunia Markvicka subsequently served several years with the sales and marketing department of Watson Pharmaceuticals with increasing responsibility.
While working for Watson, Dr. Markvicka returned to the academic environment to pursue a master of business administration from Saint Joseph’s University. After receiving her MBA, she held a series of senior positions with major pharmaceutical or consulting organizations such as The Medicines Company, Advantage Healthcare, Stack Pharmaceuticals, Pacira Pharmaceuticals, and Symbiomix.
Taunia Markvicka, PharmD, MBA has served as chief commercial officer of Symbiomix Therapeutics since March of 2016. Her responsibilities in this position include leading all aspects of pharmaceutical commercialization, from market analysis and forecasting to pre-launch and launch sales and marketing preparation, payer and channel strategy, and life-cycle management. In addition, her responsibly included investor presentations, and post-acquisition commercial transition leadership.